Press Releases from Cartherics (12 total)
CARTHERICS WINS 'MOST PROMISING iPSC THERAPY PIPELINE IN APAC' AT ASIA PACIFIC C …
Melbourne, Australia, 11 September 2025 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women's…
CARTHERICS TO PRESENT AT THE 2025 BIO INTERNATIONAL CONVENTION
• Cartherics' Chief Operating Officer, Dr. Ian Nisbet, will be presenting at BIO on Monday 16th June, 2025 at 1.30pm (US EDT).
Melbourne, Australia, 28 May…
CARTHERICS RAISES OVER $15 MILLION IN OVERSUBSCRIBED PRIVATE FINANCING ROUND TO …
• Financing round was significantly oversubscribed by existing investors and new private investors.
• Funding will enable the Company to progress clinical trials of its lead CAR-NK…
CARTHERICS ENTERS AGREEMENTS WITH UNIQUEST, THE UNIVERSITY OF QUEENSLAND AND THE …
• Cartherics, UniQuest and The University of Sydney enter Technology Licence Agreement for Cartherics' iPSC cell line.
• Cartherics, The University of Queensland and The University of Sydney…
CARTHERICS GRANTED EUROPEAN PATENT FOR MULTIPLE DEVELOPMENT CANDIDATES
Melbourne, Australia, 23 May 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,…
CARTHERICS EXECUTES OPTION AGREEMENT WITH THE OHIO STATE UNIVERSITY: TISSUE FACT …
Melbourne, Australia, 20 March 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,…
POSITIVE PRE-IND MEETING WITH US FDA FOR NEW OVARIAN CANCER CELL THERAPY
Melbourne, Australia, 1 February 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,…
Cartherics appoints new Chief Scientific Officer
Melbourne, Australia, 17 October 2023 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,…
Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Gr …
Melbourne, Australia, 28 April 2023 - Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today…
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop A …
Melbourne, Victoria, Australia; 27 February 2023
Peter MacCallum Cancer Centre ("Peter Mac") and Cartherics Pty Ltd ("Cartherics") announced today they have entered into a Collaborative Development…
Cartherics granted first patent in China for multiple development candidates
Melbourne, Australia, 09 January 2023 - Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that…
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop A …
Melbourne, Victoria, Australia; 08 November 2022: The Peter MacCallum Cancer Centre ("Peter Mac") and Cartherics Pty Ltd ("Cartherics") announced today they have entered into a…
Go To Page:
